189 related articles for article (PubMed ID: 18983299)
1. A partial nucleated differential cell count of the bone marrow aspirate that is independent of peripheral blood dilution.
Lee SH; Ho SJ; Thomas DT; Giri P; Lee H; Sia H; To LB; Sullivan TR
Int J Lab Hematol; 2008 Dec; 30(6):473-9. PubMed ID: 18983299
[TBL] [Abstract][Full Text] [Related]
2. Normalization of bone marrow aspirates for hemodilution in flow cytometric analyses.
Loken MR; Chu SC; Fritschle W; Kalnoski M; Wells DA
Cytometry B Clin Cytom; 2009 Jan; 76(1):27-36. PubMed ID: 18548614
[TBL] [Abstract][Full Text] [Related]
3. High incidence of apoptosis in peripheral blood of myelodysplastic syndrome patients determined by Papanicolaou-stained preparations.
Emura I
Lab Hematol; 2003; 9(1):42-6. PubMed ID: 12661827
[TBL] [Abstract][Full Text] [Related]
4. Automation of bone marrow aspirate examination using the XE-2100 automated hematology analyzer.
Mori Y; Mizukami T; Hamaguchi Y; Tsuruda K; Yamada Y; Kamihira S
Cytometry B Clin Cytom; 2004 Mar; 58(1):25-31. PubMed ID: 14994372
[TBL] [Abstract][Full Text] [Related]
5. [Preliminary study of biological characteristics of myelodysplastic syndromes clonal cells].
Li X; Wu LY; Ying SX; Chang CK; He Q; Song LQ; Pu Q
Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):478-83. PubMed ID: 18072633
[TBL] [Abstract][Full Text] [Related]
6. Association between phenotypic features of blasts and the blast percentage in bone marrow of patients with myelodysplastic syndromes.
Ogata K; Satoh C; Hyodo H; Tamura H; Dan K; Yoshida Y
Leuk Res; 2004 Nov; 28(11):1171-5. PubMed ID: 15380341
[TBL] [Abstract][Full Text] [Related]
7. Total nucleated cell differential for blood and bone marrow using a single tube in a five-color flow cytometer.
Björnsson S; Wahlström S; Norström E; Bernevi I; O'Neill U; Johansson E; Runström H; Simonsson P
Cytometry B Clin Cytom; 2008 Mar; 74(2):91-103. PubMed ID: 18061952
[TBL] [Abstract][Full Text] [Related]
8. [Prospective clinical study of diagnosis and classification for 282 cases with primary myelodysplastic syndrome].
Wang XQ;
Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):546-9. PubMed ID: 17172130
[TBL] [Abstract][Full Text] [Related]
9. A method for quantification of peripheral blood admixture in bone marrow aspirates.
Holdrinet RS; von Egmond J; Wessels JM; Haanen C
Exp Hematol; 1980 Jan; 8(1):103-7. PubMed ID: 7409031
[TBL] [Abstract][Full Text] [Related]
10. Multiparameter flow cytometric analysis reveals low percentage of bone marrow hematogones in myelodysplastic syndromes.
Maftoun-Banankhah S; Maleki A; Karandikar NJ; Arbini AA; Fuda FS; Wang HY; Chen W
Am J Clin Pathol; 2008 Feb; 129(2):300-8. PubMed ID: 18208811
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric assessment of peripheral blood contamination and proliferative activity of human bone marrow cell populations.
Abrahamsen JF; Lund-Johansen F; Laerum OD; Schem BC; Sletvold O; Smaaland R
Cytometry; 1995 Jan; 19(1):77-85. PubMed ID: 7705188
[TBL] [Abstract][Full Text] [Related]
12. Aggressive characteristics of myeloblasts expressing CD7 in myelodysplastic syndromes.
Satoh C; Tamura H; Yamashita T; Tsuji T; Dan K; Ogata K
Leuk Res; 2009 Feb; 33(2):326-31. PubMed ID: 18718658
[TBL] [Abstract][Full Text] [Related]
13. Hemogram and bone marrow morphology in children with chronic aplastic anemia and myelodysplastic syndrome.
Wen JQ; Feng HL; Wang XQ; Pang JP
World J Pediatr; 2008 Feb; 4(1):36-40. PubMed ID: 18402250
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of pronormoblasts in erythrocyte predominant myelodysplastic patients.
Mazzella FM; Smith D; Horn P; Cotelingam JD; Rector JT; Shrit MA; Pesce A; Schumacher HR
Am J Hematol; 2006 Jul; 81(7):484-91. PubMed ID: 16755568
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of maturation-associated phenotypic abnormalities in myelodysplastic syndromes.
Lorand-Metze I; Califani SM; Ribeiro E; Lima CS; Metze K
Leuk Res; 2008 Feb; 32(2):211-3. PubMed ID: 17675154
[TBL] [Abstract][Full Text] [Related]
16. Reduction in multi-lineage and erythroid progenitors distinguishes myelodysplastic syndromes from non-malignant cytopenias.
Vercauteren SM; Bashashati A; Wu D; Brinkman RR; Eaves C; Eaves A; Karsan A
Leuk Res; 2009 Dec; 33(12):1636-42. PubMed ID: 19414193
[TBL] [Abstract][Full Text] [Related]
17. Label-free imaging and identification of typical cells of acute myeloid leukaemia and myelodysplastic syndrome by Raman microspectroscopy.
Vanna R; Ronchi P; Lenferink AT; Tresoldi C; Morasso C; Mehn D; Bedoni M; Picciolini S; Terstappen LW; Ciceri F; Otto C; Gramatica F
Analyst; 2015 Feb; 140(4):1054-64. PubMed ID: 25568900
[TBL] [Abstract][Full Text] [Related]
18. Automated analysis of bone marrow aspirates from dogs with haematological disorders.
Tan E; Abrams-Ogg AC; Defarges A; Bienzle D
J Comp Pathol; 2014 Jul; 151(1):67-79. PubMed ID: 24726417
[TBL] [Abstract][Full Text] [Related]
19. Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disorders.
Lorand-Metze I; Ribeiro E; Lima CS; Batista LS; Metze K
Leuk Res; 2007 Feb; 31(2):147-55. PubMed ID: 16750852
[TBL] [Abstract][Full Text] [Related]
20. Quantification of nucleated red blood cells in allogeneic marrow graft and impact of processing on recovery.
Marolleau JP; Vanneaux V; Rea D; Ternaux B; Delasse V; Hubert V; Chantre E; Traineau R; Robin M; Benbunan M; Socié G; Larghero J
Transfusion; 2007 Feb; 47(2):266-71. PubMed ID: 17302773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
